YLS develops a medical device to help clinicians treat patients without the need for an organ transplant & hospitalisation.
YLS is developing a bio-medical device: Bio-engineered Artificial Ectopic Liver (BAEL), aimed at helping clinicians to treat patients suffering from liver failure while eliminating the need for an organ transplant, hospitalization, and exorbitant expenditure on the treatment.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 30, 2021 | Seed | $1.20M | 2 | Venture Catalysts Indian Scientific Innovation Company | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Venture Catalysts | Yes | Seed |
Indian Scientific Innovation Company | Yes | Seed |